Scientific work for molecular mechanisms of Interferon-β in the treatment of Multiple Sclerosis

Εκτυπώστε το άρθρο Email This Post
Post2PDF

Interferon-β (IFN-β) is approved to treat relapsing forms of multiple sclerosis (MS). The response in the treatment with IFN-β varies from beneficial to deleterious depending the individual. Scientific work has begun to bring new evidence according to molecular mechanisms of IFN-β.

Download the poster from here:

http://www.nature.com/ni/extra/ifn_ms/pdf/ifn_ms.pdf

Share
Εκτυπώστε το άρθρο Email This Post Post2PDF

web design

WebOlution